glp-1 obesity drugs analogs, new trend in treatment, become even more effective < Pharma < Article GLP-1 Medications: Everything You Need

GLP-1 is a hormone released from the gut after meals that: Stimulates insulin release when blood sugar is high Reduces glucagon levels Slows stomach emptying Signals satiety to the brain Modern GLP-1based medications (semaglutide alone and tirzepatide as a dual GIP/GLP-1 agonist) mimic or combine these effects

This product has not been evaluated by the Food and Drug Administration

Any samples are for illustrative and/or educational purposes only and should not be relied on in determining how a specific Provider will be reimbursed

Viking Therapeutics Today VKTX Viking Therapeutics $37.08 +0.71 (+1.95%) As of 07/17/2026 04:00 PM Eastern 52-Week Range $22.96 $43.15 Price Target $93.60 Viking is developing VK2735 in both oral and injectable forms and should begin Phase 3 trials for the oral form in the coming months

Caudal brainstem integration is sufficient for anorectic responses to central and to peripheral GLP-1R agonist treatment with endogenous hindbrain GLP-1R activity contributing to satiation control